BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells
<h3>Introduction</h3><p dir="ltr">Venetoclax (VCX) is a selective BCL-2 inhibitor approved for the treatment of leukemia and lymphoma. However, the mechanisms of anti-cancer effect of VCX either as a monotherapy or in combination with other chemotherapeutic agents against...
محفوظ في:
| المؤلف الرئيسي: | Ali Alhoshani (3720718) (author) |
|---|---|
| مؤلفون آخرون: | Fahad O Alatawi (16555622) (author), Fawaz E Al-Anazi (16555625) (author), Ibraheem M. Attafi (14151735) (author), Asad Zeidan (8879705) (author), Abdelali Agouni (181926) (author), Heba M El Gamal (16555631) (author), Licia S Shamoon (16555641) (author), Sarah Khalaf (16555642) (author), Hesham M Korashy (16555645) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound
حسب: Ben-Daya, Mohamed
منشور في: (2021) -
Over Fifty Years of Life, Death, and Cannibalism: A Historical Recollection of Apoptosis and Autophagy
حسب: Mahmoud Izadi (12899508)
منشور في: (2021) -
Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy
حسب: Abdullah, Al-Dhfyan
منشور في: (2022) -
Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma
حسب: Peter Kubatka (11008854)
منشور في: (2020) -
Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways
حسب: Maha Al-Tamimi (17280550)
منشور في: (2022)